paclitaxel has been researched along with Cancer of Parotid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, A; Hirano, S; Kinoshita, S; Konishi, E; Mitsuda, J; Mori, D; Ozawa, S; Saburi, S; Takenaka, M; Tsujikawa, T; Yoshimura, K | 1 |
Canales Ugarte, S; Cassinello Espinosa, J | 1 |
2 other study(ies) available for paclitaxel and Cancer of Parotid
Article | Year |
---|---|
Radiation-induced angiosarcoma of the parotid gland after postoperative radiotherapy for hypopharyngeal carcinoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Diagnosis, Differential; Female; Hemangiosarcoma; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Parotid Neoplasms; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck | 2019 |
Cerebral and parotid metachronous metastases from an ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Anticonvulsants; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Parotid Neoplasms; Supratentorial Neoplasms; Topotecan | 2006 |